A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

University of Miami, Miami

Baptist Cancer Center, Memphis

Community Health Network, Indianapolis

Karmanos Cancer Institute, Detroit

Capital Regional Medical Center, Jefferson City

MD Anderson Cancer Center, Houston

Texas Children's Hospital (Baylor College of Medicine), Houston

Huntsman Cancer Institute, Salt Lake City

HonorHealth, Scottsdale

St. Joseph's Hospital at Orange, Orange

Stanford Hospitals and Clinics, Stanford

Massachusetts General Hospital, Boston